Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 28;9:830673. doi: 10.3389/fmed.2022.830673

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Wang, Song, Liu, Zhang, Zhang, Wang, Fu, Wang, Yao, Xu, Xia, Lou, Liu, Lin, Wang, Zhao, Zhang, Cheng, Guo, Guo, Xue, Wang, Han, Zhao, Li, Zhang, Zhao, Ma, Yao, Li, Yang, Fang, Chen, Li, Shen, Sun and Kong.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The Kaplan–Meier survival analysis showed significant differences between the three groups [p < 0.001 (Total)] and pairwise comparisons {p = 0.004 [partial metabolic disorder patients (PMDP)/free metabolic disorder in patients (FMDPs)], p < 0.001 [metabolic syndrome in patients (MetSP)/FMDP], p = 0.002 [metabolic syndrome in patients (MetSPs)/PMDP]} also showed noteworthy differences in EC. The MetSP group had the best progression-free survival (PFS), followed by PMDP group and then the FMDP group.